Patent expiration of ‘Baraclude’ different from Cialis

A large blockbuster market worth of KRW 150 billion sales will be opened. However, it was analyzed its generic market will be limited. It basically proves the importance of new drug development and the present condition of domestic pharmaceuticals up to their necks in introduced products, simultaneously.

‘Baraclude,’ a hepatitis B treatment which will be expired in patent on the 9^th of October...